Takeda Pharmaceuticals U.S.A., Inc.
FDA inspection history in Brooklyn Park, Minnesota, 2020
- 1
- Form 483
Every document, by year
- Form 483
2020: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One Form 483, at Brooklyn Park, Minnesota.
Cited most
Across all Takeda Pharmaceuticals U.S.A. observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.67Equipment cleaning and maintenance1
The complete Takeda Pharmaceuticals U.S.A. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Brooklyn Park, Minnesota
One Form 483 · 2020 · 3 observations
Latest: Form 483, Mar 18, 2020 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-03-18 | 483 Form 483 | Brooklyn Park, Minnesota | 3 | $99 |
Investigators on these documents
Bo Chi (1)Eric Hales (1)Kristen Nickens (1)Scott A. Golladay (1)
FEI number 3013514239 · most recent document Mar 18, 2020
About Takeda Pharmaceuticals U.S.A., Inc.
How many FDA Form 483s has Takeda Pharmaceuticals U.S.A., Inc. received?
FDA Intel has 1 Form 483 on file for Takeda Pharmaceuticals U.S.A., Inc.; the most recent is dated Mar 18, 2020.
When was Takeda Pharmaceuticals U.S.A., Inc. last inspected by FDA?
The most recent FDA inspection document on file for Takeda Pharmaceuticals U.S.A., Inc. is a Form 483 dated Mar 18, 2020, for the site in Brooklyn Park, Minnesota.
What did FDA cite at Takeda Pharmaceuticals U.S.A., Inc.?
The regulations cited most in the observations on file for Takeda Pharmaceuticals U.S.A., Inc. are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time; 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time.